Clinical trial
Acid-Base Composition With Use of hemoDialysates: the ABChD Trial
NCT02334267 is registered in ClinicalTrials.gov with Fresenius Medical Care North America as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acid-Base Composition With Use of hemoDialysates: the ABChD Trial
- Lead sponsor
- Fresenius Medical Care North America
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- September 30, 2015
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease